IRVINE, CA--(Marketwire - May 30, 2012) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Goldman Sachs 33rd Annual Global Healthcare Conference at Terranea in Rancho Palos Verdes, California on Wednesday, June 6, 2012.
Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief financial officer, is scheduled to speak to conference attendees at 2:40 p.m. PDT. A live webcast of the discussion will be available to all interested parties on the Edwards Lifesciences investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.